GlassScriptPhysician profile
Hoa H Tran
NPI 1386841203
$9,242.70
in general payments reported to CMS, 2019-2025
54 companies · $1,373 in 2025
The $1,373 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $215 · 2020: $228 · 2021: $1,327 · 2022: $1,987 · 2023: $2,361 · 2024: $1,753 · 2025: $1,373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,376 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,376.26 |
| Education | $110.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,681.83 | 2020-2025 | Vraylar, Ubrelvy, Qulipta |
| Lilly USA, LLC | $1,015.79 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $761.05 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Otsuka America Pharmaceutical, INC. | $449.87 | 2020-2024 | Rexulti |
| Lundbeck LLC | $446.53 | 2022-2025 | Vyepti, Rexulti |
| Amgen INC. | $431.12 | 2019-2025 | Repatha, Otezla, Repatha |
| Ironshore Pharmaceuticals INC. | $370.92 | 2023-2024 | Jornay Pm |
| Pfizer INC. | $333.87 | 2023-2025 | |
| Astellas Pharma US INC | $332.24 | 2021-2024 | Veozah, Myrbetriq |
| Abbott Laboratories | $311.33 | 2022-2025 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $297.23 | 2020-2025 | Airsupra, Farxiga, Breztri |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $278.03 | 2021-2025 | Xifaxan, Trulance |
| Biohaven Pharmaceutical Holding Company LTD. | $271.35 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $255.67 | 2022-2025 | Caplyta |
| Biohaven Pharmaceuticals, INC. | $254.35 | 2021 |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hoa Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.